Protalix BioTherapeutics, Inc. (PLX) — research page
US · us-cm-kg/NYSE/PLX · as of 2026-11-08
Identity and listing
Protalix BioTherapeutics, Inc. is listed on the NYSE under the ticker PLX, with ISIN US74365A3095 and LEI 549300SDVB3GP4XDFM60. Its security type is Corporate, its segment is not on the record, and its sector is 2836 Biological Products, (No Diagnostic Substances). Its jurisdiction is United States — Delaware. Its listing status is listed, not halted.
| field | value | source · read date |
|---|---|---|
| name | Protalix BioTherapeutics, Inc. | source · 2026-11-08 |
| exchange | NYSE | source · 2026-11-08 |
| ticker | PLX | source · 2026-11-08 |
| ISIN | US74365A3095 | source · 2026-10-05 |
| LEI | 549300SDVB3GP4XDFM60 | source · 2026-11-08 |
| security type | Corporate | source · 2026-11-08 |
| segment | not on the record | |
| sector | 2836 Biological Products, (No Diagnostic Substances) | source · 2026-11-08 |
| jurisdiction | United States — Delaware | source · 2026-11-08 |
| status | listed, not halted | source · 2026-11-08 |
The disclosure read
The record holds 33 filings in the twelve months to 2026-11-08, on 20 filing days. The filings are 2 agm_egm, 5 corporate_news, 12 directors_dealings, 6 regulatory_filing and 8 results. The median gap between filing days is 13 days. The latest filing is a regulatory_filing dated 2026-10-15, 24 days before the record date. On the NYSE the median filings count is 64.0, the median cadence gap is 6.0 days and the median latency is 4.0 days across 3256 issuers. In sector 2836 the median filings count is 65.5, the median cadence gap is 5.5 days and the median latency is 4.0 days across 176 issuers.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 33 | 13 | 24 |
| exchange median: NYSE (3256 issuers) | 64 | 6 | 4 |
| sector median: 2836 Biological Products, (No Diagnostic Substances) (176 issuers) | 65.5 | 5.5 | 4 |
| date | type | category | filing |
|---|---|---|---|
| 2026-10-15 | regulatory_filing | SCHEDULE 13G | SCHEDULE 13G |
| 2026-09-09 | directors_dealings | 4 | 4 |
| 2026-09-04 | directors_dealings | 4 | 4 |
| 2026-09-04 | directors_dealings | 4 | 4 |
| 2026-09-04 | directors_dealings | 4 | 4 |
window 2025-11-08 to 2026-11-08 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor of record is Kesselman & Kesselman C.P.A.s, located in Tel Aviv, Israel. The record holds no auditor changes.
Events and halts
The record holds no listing, delisting or name change lines. Domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. Segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted.
Orderability
The outcome is not determinable. The chapter's orderability section carries no client_categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.
rule acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
No research houses were found on the issuer's own investor-relations page. The count is 0.
Open research
No openly published research notes were found. The count is 0.
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The record holds sealed years 2021, 2022, 2023, 2024, 2025 and 2026 for this issuer. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12, and the market's vintage is sealed.
Sources
9 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
- 10.2
- https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin)
- 10.3
- https://data.sec.gov/submissions/CIK0001006281.json (identity.jurisdiction)
- 10.4
- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
- 10.5
- https://mcp.us-cm-kg.ai/events/NYSE/PLX (the disclosure lines)
- 10.6
- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
- 10.7
- https://www.sec.gov/Archives/edgar/data/1006281/000110465926029858/plx-20251231x10k.htm (the auditor)
- 10.8
- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.9
- https://mcp.us-cm-kg.ai/record/NYSE/PLX (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getissuer.ai/mcp with {"isin":"US74365A3095"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:fffa33c9abc27c84.